At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
CAI Caris Life Sciences, Inc.
Market Closed 05-08 16:00:00 EDT
16.15
-3.69
-18.60%
盘后16.19
+0.04+0.22%
19:57 EDT
High17.39Low15.71Vol8.87M
Open16.80D1 Closing19.84Amplitude8.47%
Mkt Cap4.56BTradable Cap1.48BTotal Shares282.15M
T/O144.07MT/O Rate9.65%Tradable Shares91.92M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Caris Life Sciences submits application to NYSDOH for Caris Assure testing
TIPRANKS  ·  05-09 07:01
Caris Life Sciences submits application to NYSDOH for Caris Assure testing
Caris Life Sciences Submits Application for Molecular Profiling Test in New York State
MT Newswires Live  ·  05-09 04:25
Caris Life Sciences Submits Application for Molecular Profiling Test in New York State
Caris Life Sciences Submits Application to New York State Department of Health for Caris Assure Blood‑Based Testing Authorization
THOMSON REUTERS  ·  05-09 04:07
Caris Life Sciences Submits Application to New York State Department of Health for Caris Assure Blood‑Based Testing Authorization
Caris submits NY health department review application for Caris Assure blood test authorization
Reuters  ·  05-09 04:06
Caris submits NY health department review application for Caris Assure blood test authorization
Stock Track | Caris Life Sciences Plummets 15.32% Intraday Despite Earnings Beat on Quarterly Loss and Analyst Estimate Revisions
Stock Track  ·  05-08 21:38
Stock Track | Caris Life Sciences Plummets 15.32% Intraday Despite Earnings Beat on Quarterly Loss and Analyst Estimate Revisions
Caris Life Sciences, Inc. (CAI) Gets a Hold from Piper Sandler
TIPRANKS  ·  05-08 21:00
Caris Life Sciences, Inc. (CAI) Gets a Hold from Piper Sandler
Guggenheim Sticks to Its Buy Rating for Caris Life Sciences, Inc. (CAI)
TIPRANKS  ·  05-08 19:39
Guggenheim Sticks to Its Buy Rating for Caris Life Sciences, Inc. (CAI)
Caris Life Sciences price target lowered to $28 from $35 at Citi
TIPRANKS  ·  05-08 19:34
Caris Life Sciences price target lowered to $28 from $35 at Citi
Caris Life Sciences Is Maintained at Buy by BTIG
Dow Jones  ·  05-08 18:47
Caris Life Sciences Is Maintained at Buy by BTIG
CAI Corp Shareholders Unanimously Back Board, Auditor and Capital Mandates at AGM
TIPRANKS  ·  05-08 16:41
CAI Corp Shareholders Unanimously Back Board, Auditor and Capital Mandates at AGM
Stock Track | Caris Life Sciences Plunges 9.83% in Pre-market Despite Earnings Beat Amid Quarterly Loss and Estimate Revisions
Stock Track  ·  05-08 16:16
Stock Track | Caris Life Sciences Plunges 9.83% in Pre-market Despite Earnings Beat Amid Quarterly Loss and Estimate Revisions
Stock Track | Caris Life Sciences Plunges 10.28% in Extended Trading Despite Earnings Beat
Stock Track  ·  05-08 15:41
Stock Track | Caris Life Sciences Plunges 10.28% in Extended Trading Despite Earnings Beat
Analyst Reiterates Buy as Strong Revenue, Improving Profitability Offset Near-Term Risks; Price Target Trimmed to $31
TIPRANKS  ·  05-08 14:35
Analyst Reiterates Buy as Strong Revenue, Improving Profitability Offset Near-Term Risks; Price Target Trimmed to $31
Caris Life Sciences Earnings Call Signals Profitable Surge
TIPRANKS  ·  05-08 10:50
Caris Life Sciences Earnings Call Signals Profitable Surge
Caris Life Sciences Inc reports results for the quarter ended March 31 - Earnings Summary
Reuters  ·  05-08 08:03
Caris Life Sciences Inc reports results for the quarter ended March 31 - Earnings Summary
Caris Lifesciences Shares Slump in Extended Trade Following Results, Last Down 14.6% at $16.94
THOMSON REUTERS  ·  05-08 05:40
Caris Lifesciences Shares Slump in Extended Trade Following Results, Last Down 14.6% at $16.94
Caris Life Sciences reports Q1 EPS 0c, consensus (2c)
TIPRANKS  ·  05-08 05:18
Caris Life Sciences reports Q1 EPS 0c, consensus (2c)
Caris Life Sciences still sees 2026 revenue $1.0B-$1.02B, consensus $1.01B
TIPRANKS  ·  05-08 05:17
Caris Life Sciences still sees 2026 revenue $1.0B-$1.02B, consensus $1.01B
Earnings Flash (CAI) Caris Life Sciences Posts Q1 EPS $0.0, vs. FactSet Est of -$0.02
MT Newswires Live  ·  05-08 05:17
Earnings Flash (CAI) Caris Life Sciences Posts Q1 EPS $0.0, vs. FactSet Est of -$0.02
Caris Life Sciences Q1 revenue rises on demand for molecular profiling services
Reuters  ·  05-08 04:52
Caris Life Sciences Q1 revenue rises on demand for molecular profiling services

Introduction

Company Name.
Caris Life Sciences, Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Caris Life Sciences, Inc. is a leading patient-centered next-generation artificial intelligence technology biology company and precision medicine pioneer. It develops and commercializes innovative solutions to transform health care through the large-scale use of comprehensive molecular information and AI/ML algorithms. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology and serving the clinical, academic and biopharmaceutical markets.
Issue price:
--